Byline: Nora Dunne
-
Overcoming Barriers to Clinical Trial Participation
Patients with cancer who watched personalized educational videos before their first visit with an oncologist were better equipped to consider participating in clinical trials, reports a paper co-authored by Northwestern Medicine investigator Al B. Benson, III, MD.
-
Inherited Neandertal DNA Influences Human Disease Risk Today
Rex Chisholm, PhD, vice dean of Scientific Affairs and Graduate Education, co-authored two recent papers that used electronic health records to explore patient genetic data, including genes inherited from early humans.
-
Wellness Program Supports Faculty
Feinberg’s Faculty Wellness Program is a free and confidential service to help faculty members address personal and professional problems.
-
Decoding How the Brain Generalizes Information
New Northwestern Medicine research explored how dopamine regulates stimulus generalization, highlighting a potential target for future treatments to help patients with psychiatric disorders.
-
Nemmers Prize in Medical Science Announced
Huda Zoghbi, MD, Howard Hughes Medical Institute investigator and Baylor College of Medicine professor known for her groundbreaking research on Rett syndrome and other neurological disorders, is the inaugural recipient of the Mechthild Esser Nemmers Prize in Medical Science.
-
Understanding Mysterious Gene Silencer
A transcription factor protein may play an important role regulating genomic imprinting, a phenomenon where one of the two gene copies inherited from parents is silenced.
-
Northwestern 10th in World Ranking of Highly Cited Researchers
Northwestern University ranks 10th among worldwide institutions with the most highly cited researchers in 2015. The Thomson Reuters analysis includes nine Feinberg faculty members.
-
Targeting Upper Motor Neurons to Treat ALS
Scientists showed that it is possible to specifically modify gene expression in diseased upper motor neurons in a new Northwestern Medicine translational study.
-
Assessing Drug Treatment for Sickest Hepatitis C Patients
A phase III clinical trial including Northwestern Medicine investigator Steven Flamm, MD, tested a new combination of antiviral drugs for hepatitis C patients with late-stage cirrhosis.
-
Medical Student Focuses on Cancer Research
First-year medical student Martin Mutonga was the first author of a recent paper that identified a potential drug target in acute lymphoblastic leukemia.
